These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
709 related articles for article (PubMed ID: 8778798)
1. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland. Snedeker SM; Diaugustine RP Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798 [TBL] [Abstract][Full Text] [Related]
2. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500 [TBL] [Abstract][Full Text] [Related]
3. Potential benefits of estrogens and progestogens on breast cancer. Schneider HP; Jackisch C Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536 [TBL] [Abstract][Full Text] [Related]
4. [Cancer risk under hormone therapy]. Lauritzen C Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer epidemiology. Kelsey JL; Berkowitz GS Cancer Res; 1988 Oct; 48(20):5615-23. PubMed ID: 3048646 [TBL] [Abstract][Full Text] [Related]
7. The pill and the breast. Drife JO IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402 [TBL] [Abstract][Full Text] [Related]
8. Prolactin and breast carcinoma. Smithline F; Sherman L; Kolodny D N Engl J Med; 1975 Apr; 292(15):784-92. PubMed ID: 1089886 [TBL] [Abstract][Full Text] [Related]
9. Effect of endogenous and exogenous hormones on breast cancer: epidemiology. Vessey MP Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk with postmenopausal hormonal treatment. Collins JA; Blake JM; Crosignani PG Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk in the WHI study: the problem of obesity. Kuhl H Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113 [TBL] [Abstract][Full Text] [Related]
12. [The present state of research on the relationship of oral contraceptives to breast cancer]. Pike MC Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203 [TBL] [Abstract][Full Text] [Related]
13. Effects of sex steroids on proliferation in normal mammary tissue. Söderqvist G Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352 [TBL] [Abstract][Full Text] [Related]
15. Hormones and breast cancer. ESHRE Capri Workshop Group Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054 [TBL] [Abstract][Full Text] [Related]
16. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
17. Endogenous and exogenous endocrine factors. Henderson BE Hematol Oncol Clin North Am; 1989 Dec; 3(4):577-98. PubMed ID: 2691490 [TBL] [Abstract][Full Text] [Related]
18. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related]
19. Cellular basis of breast cancer susceptibility. Russo J; Russo IH Oncol Res; 1999; 11(4):169-78. PubMed ID: 10566615 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition. Mueck AO; Seeger H; Wallwiener D Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]